Modification of antioxidative and antiapoptotic genes expression in irradiated K562 cells upon fullerenol C60(OH)24 nanoparticle treatment

J Nanosci Nanotechnol. 2013 Jan;13(1):105-13. doi: 10.1166/jnn.2013.6847.

Abstract

Recent data established the prospective applications for fullerenol (C60(OH)24) nanoparticle (FNP) in many fields, such as antioxidants, neuroprotective agents, and potential anti-radiation drugs. Leukemia cell sensitization to apoptosis induced by ionizing radiation is achieved by upregulation of ROS production and/or downregulation of antioxidative enzymes. Therefore, our aim was to analyze the potential role of fullerenol nanoparticle in modulation of the leukemic cellular response to irradiation. We used the qRT-PCR to analyze the expression level of mRNA for 11 genes in irradiated and FNP pre-treated irradiated K562 cells, and compared the gene expression level with the overall cell survival. Our results of the improved cell survival in FNP-treated irradiated cells and significant overexpression of anti-apoptotic Bcl-2 and Bcl-xL and cytoprotective genes such as GSTA4, MnSOD, NOS, CAT and HO-1 genes, may indicate that FNP exerts cytoprotective function in K562 leukemic cells, rendering K562 cells more tolerant to radiotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / metabolism*
  • Cell Survival / drug effects*
  • Cell Survival / radiation effects*
  • Fullerenes / administration & dosage*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / radiation effects
  • Humans
  • K562 Cells
  • Nanoparticles / administration & dosage*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Radiation-Protective Agents / administration & dosage
  • bcl-X Protein / metabolism*

Substances

  • Antioxidants
  • BCL2L1 protein, human
  • Fullerenes
  • Proto-Oncogene Proteins c-bcl-2
  • Radiation-Protective Agents
  • bcl-X Protein
  • fullerene C60